UroGen Pharma
URGN
URGN
165 hedge funds and large institutions have $1.02B invested in UroGen Pharma in 2025 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 160 → 165 (+5)
2% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 52
1.69% less ownership
Funds ownership: 95.05% → 93.36% (-1.7%)
Holders
165
Holding in Top 10
4
Calls
$33.9M
Puts
$7.2M
Top Buyers
| 1 | +$29.5M | |
| 2 | +$24.4M | |
| 3 | +$17.5M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$17M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$13.7M |
Top Sellers
| 1 | -$63.7M | |
| 2 | -$18.4M | |
| 3 | -$14.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$11.5M |
| 5 |
JP Morgan Chase
New York
|
-$8.42M |
